Founded 2008
Public 2016 (NASDAQ: EIGR)
Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development and commercialization of a broad range of therapeutics, with special expertise in Orphan Designation drugs.
Contact
(P) 650-272-6138
(F) 650-618-1621
www.eigerbio.com
Info@eigerbio.com
Location: United States, California, Palo Alto
Member count: 11-50
Phone: (650) 272-6138
Total raised: $7.1M
Founded date: 2008
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 04.02.2009 | - | $7.1M | - | venturebea... |
Mentions in press and media 27
| Date | Title | Description | Category | Author | Source |
| 06.01.2022 | Eiger BioP... | PALO ALTO, Calif., Jan. 6, 202... | - | - | marketscre... |
| 22.12.2021 | Eiger BioP... | PALO ALTO, Calif., Dec. 21, 20... | - | - | marketscre... |
| 15.12.2021 | Eiger BioP... | PALO ALTO, Calif., Dec. 15, 20... | - | - | marketscre... |
| 01.12.2021 | Eiger BioP... | PALO ALTO, Calif., Dec. 1, 202... | - | - | marketscre... |
| 01.11.2021 | Eiger BioP... | PALO ALTO, Calif., Nov. 1, 202... | - | - | marketscre... |
| 20.09.2021 | Eiger BioP... | PALO ALTO, Calif., Sept. 20, 2... | - | - | marketscre... |
| 05.08.2021 | Eiger BioP... | PALO ALTO, Calif., Aug. 5, 202... | - | - | marketscre... |
| 05.08.2021 | Eiger Anno... | PALO ALTO, Calif., Aug. 5, 2... | - | - | prnewswire... |
| 06.07.2021 | Eiger BioP... | PALO ALTO, Calif., July 6, 2... | - | - | prnewswire... |
| 06.07.2021 | Eiger BioP... | PALO ALTO, Calif., July 6, 202... | - | - | marketscre... |
Show more